PMID: 41864588

Low-dose telmisartan protects against myocardial ischemia/reperfusion injury via dual mechanisms: AMPK activation and AMPK-independent calcium homeostasis.

Liu Jia, Lyu Qingguo, Li Ji, He Xiuting, Leng Jiyan

International journal of cardiology · 2026

Vol. 454, pp. 134450

View on PubMedDOI

This entry links to third-party literature. For research use only.

AnimalsTelmisartanMyocardial Reperfusion InjuryMiceAMP-Activated Protein KinasesCalciumBenzimidazolesHomeostasisMice, Inbred C57BLMale

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.